Clinical evaluation of a derivative of 6-beta-amidino penicillanic acid (preparation HX) in urinary tract infections
Musierowicz, A.; Borowski, J.; Zaremba, M.; Prokopowicz, J.; Darewicz, J.; Gruszecki, W.; Pachman, A.
Polski Tygodnik Lekarski 35(27): 1017-1019
1980
ISSN/ISBN: 0032-3756 PMID: 6252549 Document Number: 164632
Document emailed within 1 workday
Related Documents
Posada, H.R. 1970: Clinical evaluation of a new derivative of 6-amino-penicillanic acid Revista Brasileira de Medicina 27(5): 279-285Shiono, A.; Kurihara, J.; Hayashi, M.; Suzuki, T.; Imai, K.; Yamanaka, H.; Takezawa, Y.; Kiren, H.; Okabe, K.; Tomaru, Y. 1993: Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains Hinyokika Kiyo. Acta Urologica Japonica 39(8): 777-782
Mazanowska, O.; Boratyńska, M.; Mróz, E.; Starek, J. 1994: Clinical evaluation of norfloxacin preparation in treatment of bacterial infections of the urinary tract in patients with various kidney diseases Polski Tygodnik Lekarski 49(6-7): 154-157
Jastalska, D.; Dzierzyńska, I.; Buśko-Oszczapowicz, I.; Cieślak, J. 1974: Semisynthetic penicillins. 13. Comparative studies of antibacterial action in vitro of 6-(N,N-1',6'-hexylenformamidino)-penicillanic acid and(D- (D-(minus) alpha-aminobenzyl)-penicillanic acid against clinical pathogenic gram negative strains Acta Poloniae Pharmaceutica 31(3): 393-400
Martini, G.; Romano, G. 1980: Clinical results of the use of pipemidic acid in the common urinary tract infections La Clinica Terapeutica 93(1): 25-31
Hori, J.; Yamaguchi, S.; Osanai, H.; Kinebuchi, T.; Usami, K.; Takahashi, N.; Ishii, Y. 2007: Clinical study of the urinary tract infections due to Escherichia coli harboring extended-spectrum beta lactamase Hinyokika Kiyo. Acta Urologica Japonica 53(11): 777-782
Pagani, G. 1980: Clinical contribution to the study of pipemidic acid in urinary tract infections in a urology clinic La Clinica Terapeutica 94(2): 165-171
Gołabek, B.; Nowakowska, K.; Słowik, M.; Paruszkiewicz, G. 1995: Clinical evaluation of Uro-Vaxom in treatment of recurrent urinary tract infections in girls Pediatria Polska 70(12): 1053-1057
Solbiati, M.; Danzi, M.C.; D'Orazio, C.; Bassetti, D. 1988: Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(6): 393-395
Furusawa, T.; Itakura, Y.; Miyashita, H.; Nakao, M. 1981: Clinical evaluation of the new type pivmecillinam tablet (contains 100 MG) on the treatment for female acute simple urinary tract infections Japanese Journal of Antibiotics 34(8): 1191-1195
Suzuki, K.; Horiba, M.; Naide, Y.; Shinoda, M.; Hibi, H.; Okishio, N.; Yanagioka, M.; Nagakubo, I. 1991: Clinical study of sparfloxacin, a new quinolone derivative, on urinary tract infection Hinyokika Kiyo. Acta Urologica Japonica 37(12): 1749-1757
Johnson, C.E.; Vacca, C.V.; Fattlar, D.; Fulton, D.J.; Hall, P.W. 1990: Urinary N-acetyl-beta-glucosaminidase and the selection of children for radiologic evaluation after urinary tract infection Pediatrics 86(2): 211-216
Mikołajczyk, J.; Kotulowa, W.; Kazimierczak, J.; Sikora, A.; Rogowska, W.; Cieślak, J. 1980: Beta-lactamase inhibitors. I. Synthesis and biological properties of penicillanic acid derivatives Acta Poloniae Pharmaceutica 37(6): 637-641
Lampe, W.T. 1971: Oxolinic acid treatment of urinary tract infections Pennsylvania Medicine 74(7): 59-62
Lathem, J.E.; McCoy, R.M. 1974: The treatment in office practice of urinary tract infections with nalidixic acid Journal of the South Carolina Medical Association 70(12): 386-388
Szymborski, J.; Dobek, G. 1984: Bacteriologic evaluation of urinary tract infections in children Wiadomosci Lekarskie 37(5): 349-355
Jaya, G.; Bal, C.S.; Padhy, A.K.; Bandopadhyaya, G.P.; Pattnayak, S.K.; Malathi, K.E. 1996: Radionuclide studies in the evaluation of urinary tract infections Indian Pediatrics 33(8): 635-640
García Victor, F.; Ferrero Doria, R. 2001: Observational study of therapy compliance in the treatment of uncomplicated urinary tract infections of the urinary tract with 500 mg ciprofloxacin suspension Archivos Espanoles de Urologia 54(4): 313-320
Joalland, F.; Cormier, H.él.èn.; Verdon, R. 2017: Understanding the place and implications of entero-bacteria producing extended-spectrum beta-lactamases in urinary tract infections? La Revue du Praticien 67(8): E397-E398
Aito, K.; Iwatsubo, E. 1970: Clinical use of Furadantin C for urinary tract infections Hinyokika Kiyo. Acta Urologica Japonica 16(11): 688-691